SAN MATEO, Calif., Feb. 19 /PRNewswire-FirstCall/ -- NeurogesX, Inc.
(Nasdaq: NGSX), a biopharmaceutical company focused on developing novel
pain management therapies, announced today that it is scheduled to present
at the Roth Capital Partners 20th Annual OC Growth Stock Conference in
Laguna Niguel, CA on February 20, 2008. Anthony DiTonno, President and
Chief Executive Officer, will be presenting and Stephen Ghiglieri, Chief
Financial Officer, will be available to respond to questions during the
break out session.
Event: Roth Capital 20th Annual OC Growth Stock Conference
Date: Wednesday, February 20, 2008
Time: 2:00 p.m. Pacific Time
Place: Ritz Carlton, Laguna Niguel, CA (Salon 3)
An audio Web cast of the Company's presentation will be available by going to the investor relations section of NeurogesX' Web site at http://www.neurogesx.com. A replay of the presentation will be available for 15 days.
About NeurogesX, Inc.
NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on
developing novel pain management therapies. Its initial focus is on chronic
peripheral neuropathic pain, including postherpetic neuralgia (PHN),
painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic
neuropathy. NeurogesX' late stage product portfolio is led by its product
candidate NGX-4010, a dermal patch designed to manage pain associated with
peripheral neuropathic pain conditions, that the company
|SOURCE NeurogesX, Inc.|
Copyright©2008 PR Newswire.
All rights reserved